1. Research Objectives and Assumptions

   • Research Objectives
   • Assumptions
   • Abbreviations

2. Market Purview

   • Report Description
     • Market Definition and Scope
   • Executive Summary
     • Market Snippet, By Pain Type
     • Market Snippet, By Drug Class
     • Market Snippet, By Indication
     • Market Snippet, By Region
   • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

   • Market Dynamics
     • Drivers
     • Restraints
     • Market Opportunities
   • Impact Analysis
   • Key Highlights
   • Product launch
   • Regulatory Scenario
   • PEST Analysis
   • Mergers and Acquisitions

4. Global Pain Management Therapeutics Market, By Pain Type, 2021-2033, (USD Bn)

   • Introduction
     • Market Share Analysis, 2026 and 2033 (%)
     • Y-o-Y Growth Analysis, 2022-2033
     • Segment Trends
   • Chronic
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
   • Acute
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

5. Global Pain Management Therapeutics Market, By Drug Class, 2021-2033, (USD Bn)

   • Introduction
     • Market Share Analysis, 2026 and 2033 (%)
     • Y-o-Y Growth Analysis, 2022-2033
     • Segment Trends
   • NSAIDS
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
   • Anesthetics
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
   • Anticonvulsant
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
   • Anti-migraine Drugs
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
   • Antidepressant Drugs
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
   • Opioids
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
   • Non-narcotics
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
   • Analgesics
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

6. Global Pain Management Therapeutics Market, By Indication, 2021-2033, (USD Bn)

   • Introduction
     • Market Share Analysis, 2026 and 2033 (%)
     • Y-o-Y Growth Analysis, 2022-2033
     • Segment Trends
   • Arthritic Pain
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
   • Neuropathic Pain
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
   • Cancer Pain
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
   • Chronic Pain
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
   • Post-operative Pain
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
   • Migraine
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
   • Fibromyalgia
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
   • Bone Fracture
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
   • Muscle Sprain/Strain
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
   • Acute Appendicitis
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
   • Others
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

7. Global Pain Management Therapeutics Market, By Region, 2021-2033, (USD Bn)

   • Introduction
     • Market Share Analysis, By Region, 2026 and 2033 (%)
     • Y-o-Y Growth Analysis, For Regions, 2022–2033
   • North America
     • Market Size and Forecast, By Pain Type, 2021-2033, (USD Bn)
     • Market Size and Forecast, By Drug Class, 2021-2033, (USD Bn)
     • Market Size and Forecast, By Indication, 2021-2033, (USD Bn)
     • Market Size and Forecast, By Country, 2021-2033, (USD Bn)
       • U.S.
       • Canada
   • Latin America
     • Market Size and Forecast, By Pain Type, 2021-2033, (USD Bn)
     • Market Size and Forecast, By Drug Class, 2021-2033, (USD Bn)
     • Market Size and Forecast, By Indication, 2021-2033, (USD Bn)
     • Market Size and Forecast, By Country, 2021-2033, (USD Bn)
       • Brazil
       • Mexico
       • Argentina
       • Rest of Latin America
   • Europe
     • Market Size and Forecast, By Pain Type, 2021-2033, (USD Bn)
     • Market Size and Forecast, By Drug Class, 2021-2033, (USD Bn)
     • Market Size and Forecast, By Indication, 2021-2033, (USD Bn)
     • Market Size and Forecast, By Country, 2021-2033, (USD Bn)
       • Germany
       • U.K.
       • France
       • Italy
       • Spain
       • Russia
       • Rest of Europe
   • Asia Pacific
     • Market Size and Forecast, By Pain Type, 2021-2033, (USD Bn)
     • Market Size and Forecast, By Drug Class, 2021-2033, (USD Bn)
     • Market Size and Forecast, By Indication, 2021-2033, (USD Bn)
     • Market Size and Forecast, By Country, 2021-2033, (USD Bn)
       • China
       • India
       • Japan
       • Australia
       • South Korea
       • ASEAN
       • Rest of APAC
   • Middle East
     • Market Size and Forecast, By Pain Type, 2021-2033, (USD Bn)
     • Market Size and Forecast, By Drug Class, 2021-2033, (USD Bn)
     • Market Size and Forecast, By Indication, 2021-2033, (USD Bn)
     • Market Size and Forecast, By Country, 2021-2033, (USD Bn)
       • GCC
       • Israel
       • Rest of Middle East
   • Africa
     • Market Size and Forecast, By Pain Type, 2021-2033, (USD Bn)
     • Market Size and Forecast, By Drug Class, 2021-2033, (USD Bn)
     • Market Size and Forecast, By Indication, 2021-2033, (USD Bn)
     • Market Size and Forecast, By Country, 2021-2033, (USD Bn)
       • South Africa
       • Central Africa
       • North Africa

8. Competitive Landscape

   • Company Profiles
     • AcelRx Pharmaceuticals, Inc.
       • Company Overview
       • Product Portfolio
       • Financial Overview
       • Key Highlights
       • Market Strategies
     • Averitas Pharma, Inc.
       • Company Overview
       • Product Portfolio
       • Financial Overview
       • Key Highlights
       • Market Strategies
     • AmerisourceBergen
       • Company Overview
       • Product Portfolio
       • Financial Overview
       • Key Highlights
       • Market Strategies
     • Cardinal Health
       • Company Overview
       • Product Portfolio
       • Financial Overview
       • Key Highlights
       • Market Strategies
     • McKesson Corporation
       • Company Overview
       • Product Portfolio
       • Financial Overview
       • Key Highlights
       • Market Strategies
     • Johnson & Johnson
       • Company Overview
       • Product Portfolio
       • Financial Overview
       • Key Highlights
       • Market Strategies
     • Teva Pharmaceuticals
       • Company Overview
       • Product Portfolio
       • Financial Overview
       • Key Highlights
       • Market Strategies
     • Abbott Laboratories
       • Company Overview
       • Product Portfolio
       • Financial Overview
       • Key Highlights
       • Market Strategies
     • Allergan, Inc.
       • Company Overview
       • Product Portfolio
       • Financial Overview
       • Key Highlights
       • Market Strategies
     • Covidien plc
       • Company Overview
       • Product Portfolio
       • Financial Overview
       • Key Highlights
       • Market Strategies
     • Durect Corporation
       • Company Overview
       • Product Portfolio
       • Financial Overview
       • Key Highlights
       • Market Strategies
     • Eli Lilly and Company
       • Company Overview
       • Product Portfolio
       • Financial Overview
       • Key Highlights
       • Market Strategies
     • Endo Health Solutions, Inc
       • Company Overview
       • Product Portfolio
       • Financial Overview
       • Key Highlights
       • Market Strategies
     • Forest Laboratories, Inc.
       • Company Overview
       • Product Portfolio
       • Financial Overview
       • Key Highlights
       • Market Strategies
     • GlaxoSmithKline plc
       • Company Overview
       • Product Portfolio
       • Financial Overview
       • Key Highlights
       • Market Strategies
     • Hospira, Inc.
       • Company Overview
       • Product Portfolio
       • Financial Overview
       • Key Highlights
       • Market Strategies
     • Merck & Co., Inc.
       • Company Overview
       • Product Portfolio
       • Financial Overview
       • Key Highlights
       • Market Strategies
     • Mundipharma International Ltd.
       • Company Overview
       • Product Portfolio
       • Financial Overview
       • Key Highlights
       • Market Strategies
     • Novartis International AG
       • Company Overview
       • Product Portfolio
       • Financial Overview
       • Key Highlights
       • Market Strategies

9. Section

   • References
   • Research Methodology
   • About us and Sales Contact